Melted ice packs or a warm parcel: what to do next

Separate the observation from the conclusion

A soft gel pack tells you its condition at the time you opened the parcel. It does not establish the highest temperature reached, how long an excursion lasted or the temperature beside every product. Equally, a pack that is still cold does not certify the whole journey. Record what you actually observed instead of deciding that the shipment is either fine or ruined.

Temperature and duration matter to an investigation. FDA guidance for biological products explains the value of recording both and consulting the manufacturer about a possible excursion. Although that guidance discusses disrupted storage and transport, the same information is useful in a delivery enquiry. Read the FDA’s temperature-record guidance.

There is no storage rule for every toxin

These examples are deliberately different. Neither label supplies a universal allowance for another brand, and neither means unlimited heat exposure is acceptable. A storage range also does not, by itself, validate a particular shipping method. Confirm the instructions for the exact product and market you received.

The table concerns unopened products only. Once a medicine has been prepared for use, different instructions may apply; that belongs to the responsible healthcare professional.

Make a clear record at receipt

• Note the delivery time and when the parcel was opened.
• Photograph the carton, insulation, coolant and product labels.
• Keep any temperature indicator or logger, including its original readings.
• Record each affected product, lot number and expiry date.
• Describe observable issues such as a warm parcel, damaged insulation or a monitoring alert.
• Keep the products separate pending guidance and promptly contact the supplier.

Do not invent missing measurements. “No temperature logger was included” is more useful than estimating an entire journey from how the carton felt. If you record a temperature at receipt, include when, where and how it was measured so that it is not mistaken for continuous monitoring.

What happens while the question is being assessed

Follow the applicable label while awaiting a response and make the hold visible to anyone handling the goods. Moving a product into its recommended storage after arrival does not prove that an earlier excursion was acceptable. The FDA advises consulting the label and a pharmacist, healthcare provider or manufacturer when temperature-sensitive medicines have not been kept as recommended. See the FDA’s advice on interrupted refrigeration.

Ask for an answer tied to the product and the available evidence. If a statement refers to a stability study, clarify whether it covers the same formulation, packaging, temperature and duration. A general reassurance about another shipment is not an assessment of yours.

Send one complete delivery enquiry

Contact The Fora team with your order reference, the affected products, photographs and any monitoring record. Explain what needs confirming and keep the written reply with the parcel details. Read Delivery for shipping information and for the return process.

Do not send the goods back or discard evidence before the next step is agreed. If the available information cannot establish suitability, a supplier or manufacturer must resolve that uncertainty; this article does not authorise use. Preparing a clear receiving record helps the investigation move forward without guessing.